Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1432
https://www.valueinhealthjournal.com/article/S1098-3015(14)03362-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
911
First Page :
A487
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03362-2&doi=10.1016/j.jval.2014.08.1432